PMID: 9526970Apr 4, 1998Paper

Metformin decreases food consumption and induces weight loss in subjects with obesity with type II non-insulin-dependent diabetes

Obesity Research
A Lee, J E Morley

Abstract

Metformin often promotes weight loss in patients with obesity with non-insulin-dependent diabetes mellitus (NIDDM). The mechanism may be attributed to decreased food intake. This study has tested the effect of metformin on satiety and its efficacy in inducing weight loss. Twelve diet-treated NIDDM women with obesity were randomly given two dose levels (850 mg or 1700 mg) of metformin or placebo at 0800 for three consecutive days followed by a meal test on the third day on three occasions using a 3x3 Latin square design. The number of sandwich canapes eaten in three consecutive 10-minute periods beginning at 1400 hours was used to quantitate food intake, and the level of subjective hunger was rated just before the sandwich meal with a linear analogue hunger rating scale at 1400 after a 6-hour fast. The prior administration of metformin produced a reduction in calorie intake after each of the two doses of metformin treatment. The 1700-mg metformin dose had the most marked appetite suppressant action. Similarly, hunger ratings were significantly lowered after metformin, and the effect was most pronounced after the administration of 1700 mg of metformin. To assess the efficacy of metformin in reducing bodyweight, 48 diet-treated NI...Continue Reading

References

Jun 1, 1992·Diabetes Care·C J Bailey
Nov 11, 1989·Lancet·B Guy-GrandP Turner
Jan 1, 1986·Neuroscience and Biobehavioral Reviews·S P Grossman
Jan 1, 1988·European Journal of Clinical Pharmacology·L G McAlpineB M Frier
Aug 1, 1987·Endocrine Reviews·J E Morley
Jul 1, 1968·British Journal of Pharmacology and Chemotherapy·J T Silverstone, A J Stunkard
Apr 5, 1969·British Medical Journal·J F MunroL J Duncan
Sep 3, 1981·The New England Journal of Medicine·A HolleH W Rüdiger
Aug 31, 1995·The New England Journal of Medicine·M StumvollJ E Gerich
Feb 1, 1996·The New England Journal of Medicine·R V ConsidineT L Bauer
Feb 29, 1996·The New England Journal of Medicine·C J Bailey, R C Turner
Nov 1, 1995·Obesity Research·L A CampfieldR W Kierstead
Jan 1, 1997·Journal of the American Dietetic Association·M W Schwartz, R J Seeley
Oct 1, 1948·Journal of Applied Physiology·M I GROSSMAN, I F STEIN

❮ Previous
Next ❯

Citations

Aug 10, 1999·Diabetes/metabolism Research and Reviews·D Kerr, D Cavan
Dec 22, 1999·Physiology & Behavior·E del PreteE Scharrer
Nov 21, 2007·Nature Clinical Practice. Endocrinology & Metabolism·Jennifer L Miller, Janet H Silverstein
Nov 17, 2012·Nutrition & Diabetes·B Perry, Y Wang
May 3, 2002·Clinical and Experimental Pharmacology & Physiology·Masami SuzukiHitoshi Ikeda
Aug 23, 2006·Cardiology in Review·Kerri L PalamaraWilliam H Frishman
Nov 24, 2004·Southern Medical Journal·William H BestermannBrent M Egan
Mar 31, 2007·International Journal of Clinical Practice·J Tibaldi, R E Rakel
Sep 29, 2005·Annals of Family Medicine·Kara M LevriStephen A Wilson
Jan 1, 2010·Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy·Jg Karam, Si McFarlane
Jun 21, 2014·Experimental & Molecular Medicine·Michelle E KimplePatrick J Casey
Jun 4, 2014·Proceedings of the National Academy of Sciences of the United States of America·Wouter De HaesLiesbet Temmerman
Sep 24, 2014·Journal of Diabetes and Metabolic Disorders·Rokhsareh AghiliMohammad Ebrahim Khamseh
Nov 19, 2014·Journal of the American Medical Directors Association·Barbara J Messinger-RapportJohn E Morley
Jun 23, 2009·Expert Opinion on Drug Safety·Joanna Mitri, Osama Hamdy
Oct 20, 2006·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·M J KimJ E Morley
Apr 25, 2007·The Aging Male : the Official Journal of the International Society for the Study of the Aging Male·Angela D Mazza, John E Morley
Oct 22, 2014·Climacteric : the Journal of the International Menopause Society·R WorsleyS R Davis
Oct 9, 2002·Current Medical Research and Opinion·Stanley H Hsia, Mayer B Davidson
Jul 17, 2015·Diabetes Care·Giulia FerranniniEle Ferrannini
Nov 2, 2013·Journal of the American Medical Directors Association·Alan Sinclair, John E Morley
Mar 20, 2012·Pharmacology, Biochemistry, and Behavior·Jiejie LiZhiyi Zuo
Oct 25, 2011·Journal of the American Medical Directors Association·Barbara J Messinger-RapportJulie K Gammack
May 31, 2011·Journal of the American Medical Directors Association·John E Morley
May 10, 2011·The Medical Clinics of North America·Debbie Tolson, John E Morley
Oct 25, 2011·Journal of the American Medical Directors Association·Alexandra MigdalGuillermo E Umpierrez
May 5, 2010·Journal of the American Medical Directors Association·John E Morley
Aug 30, 2008·Journal of the American Medical Directors Association·Barbara J Messinger-RapportJohn E Morley
Oct 13, 2007·Journal of the American Medical Directors Association·Angela D Mazza, John E Morley
Oct 13, 2007·Journal of the American Medical Directors Association·Linda B Haas
Sep 12, 2007·Journal of the American Medical Directors Association·Barbara J Messinger-RapportJulie K Gammack
Feb 20, 2007·The American Journal of Cardiology·Michelle Lee, Louis J Aronne
Dec 17, 2004·Obesity Research·Jesse RothBarbara C Lowell
Oct 21, 2010·The Mount Sinai Journal of Medicine, New York·Amulya T SiramMaria Skamagas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Biomarkers for Type 2 Diabetes

Biomarkers can help understand chronic diseases and assist in risk prediction for prevention and early detection of diseases. Here is the latest research on biomarkers in type 2 diabetes, a disease in which the body is unable to produce or properly use insulin.